Clinical studies have found that serum IL-4, IL-6, IL-10, and IL-16 levels in patients with AD are significantly higher than those in healthy individuals, and some inflammatory factors are correlated with cognitive function, language, and memory in patients with AD (Motta et al., 2007; Lu et al., 2022). The gene discussed is IL6; the disease is Alzheimer disease.